Highlights and Quick Summary
- Share Based Compensation of Revenue for the quarter ending March 31, 2023 was 131.48% (a -138.35% decrease compared to previous quarter)
- Year-over-year quarterly Share Based Compensation of Revenue increased by Infinity%
- Annual Share Based Compensation of Revenue for 2022 was 1191.78% (a Infinity% increase from previous year)
- Annual Share Based Compensation of Revenue for 2022 was 0.0% (a -100.0% decrease from previous year)
- Annual Share Based Compensation of Revenue for 2021 was 1074.58% (a Infinity% increase from previous year)
- Twelve month Share Based Compensation of Revenue ending March 31, 2023 was 425.0% (a -39.78% decrease compared to previous quarter)
- Twelve month trailing Share Based Compensation of Revenue decreased by -63.36% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| 425.0% | 705.75% | 0.0% | 1160.0% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Share Based Compensation of Revenue of Benitec Biopharma Limited
Most recent Share Based Compensation of Revenueof BNTC including historical data for past 10 years.Interactive Chart of Share Based Compensation of Revenue of Benitec Biopharma Limited
Benitec Biopharma Limited Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 131.48% | – | – | – | – |
| 2022 | -342.86% | 0.0% | 0.0% | 400.0% | 1191.78% |
| 2021 | 956.0% | 0.0% | 13950.0% | 23500.0% | 1074.58% |
| 2020 | 8200.0% | 69.09% | -158.33% | 642.86% | 232.35% |
| 2019 | – | – | 0.0% | 166.67% | 5.51% |
| 2018 | – | – | – | – | 9.22% |
| 2017 | – | – | – | 0.0% | 0.0% |
| 2016 | – | – | – | 0.0% | 43.07% |
| 2015 | – | – | – | – | 37.84% |
| 2014 | – | – | – | – | 25.85% |
| 2013 | – | – | – | – | 35.43% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology